¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ARGININE VEYRON ORAL SOLUTION"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AVP   1) Active non apeptide(?)
  2) Arginine Vaso-Pressin
AVT Arginine Vaso-Tocin
DDAVP 1-Desamino-8-D-Arginine Vasopressin
  = Desmopression
ADH Academy of Dentistry for the Handicapped; adhesion; alcohol dehydrogenase; antidiuretic hormone; arg...
AHU acute hemolytic uremic [syndrome]; arginine, hypoxanthine, and uracil
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PSS K(+)-physiological salt solution
KHS Krebs'-Henseleit solution
KRB Krebs Ringer Bicarbonate solution
LR Lactated Ringer solution
LRS Lactated Ringer's Solution
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • regular solution
    Á¤±Ô¿ë¾×
  • Ringer¡¯s lactate solution
    ¸µ°ÅÁ¥»ê¿ë¾×
  • Ringer¡¯s solution
    ¸µ°Å¿ë¾×
  • solution
    1. ¿ë¾×, ¾× 2. Ç®ÀÌ, ÇØ¹ý
  • saturated solution
    Æ÷È­¿ë¾×
  • standard solution
    Ç¥ÁØ¿ë¾×
  • stock solution
    ¿ø¾×
  • stop solution
    Á¤Áö¾×
  • supersaturated solution
    °úÆ÷È­¾×
  • sclerosing solution
    °æÈ­¾×
  • seminormal solution
    ¹Ý±ÔÁ¤¾×
  • saline solution
    ½Ä¿°¼ö
  • unsaturated solution
    ºÒÆ÷È­¾×
  • oral
    1. ÀÔ- 2. °æ±¸- 3. ±¸µÎ-, ±¸¼ú- 4. ÀÔ¾È, ±¸°­
  • oral administration
    °æ±¸Åõ¿©
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • oral mycosis
    ÀÔ¾ÈÁø±ÕÁõ, ±¸°­Áø±ÕÁõ
  • oral white sponge nevus
    ÀԾȹé»öÇØ¸é¸ð¹Ý
  • oral
    ÀÔ-, °æ±¸-, ±¸°­-
  • oral personality
    ±¸°­ÀΰÝ
  • oral pharynx
    ÀÔÀεÎ
  • oral prophylaxis
    ±¸°­¿¹¹æ
  • oral psoriasis
    ±¸°­°Ç¼±
  • oral region
    ÀÔºÎÀ§
  • oral sepsis
    ÀÔ¾ÈÆÐÇ÷Áõ
  • oral sucker
    ÀÔ»¡ÆÇ, ±¸Èí¹Ý
  • oral surgery
    ±¸°­¿Ü°ú, ±¸°­¿Ü°úÇÐ
  • oral ulcer
    ÀԱ˾ç
  • oral florid papillomatosis
    ÀԾȲÉÀ¯µÎÁ¾Áõ
  • oral glucose tolerance test
    °æ±¸Æ÷µµ´çºÎÇϰ˻ç
  • oral-facial-digital syndrome
    ÀÔ¾ó±¼¼Õ°¡¶ôÁõÈıº, ±¸°­¾È¸é¼öÁ·ÁöÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • heavy solution
    Áß¾×(ñìäû).
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö(Φ߫ûùâ©áÈ).
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö(î¸íåãÝç¤â©).
  • hypotonic solution
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû).
  • physiologic solution
    »ý¸®¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • physiological solution
    »ý¸®¿ë¾×(ßæìµéÁäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • etching solution
    ºÎ½Ä(ݯãÚ)¿ë¾×.
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • heavy solution
    Áß¾×(ñìäû).
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö(Φ߫ûùâ©áÈ).
  • hypertonic salt solution
    °íÀå½Ä¿°¼ö(ÍÔíåãÝç¤â©).
  • hypertonic solution
    °íÀå¾×(ÍÔíåäû).
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö(î¸íåãÝç¤â©).
  • hypotonic solution
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû).
  • iodine solution
    ¿äµå¿ë¾×(¡­éÁäû).
  • isohydric solution
    µî¼ö¿ë¾×(¡­éÁäû).
  • isotonic sodium chloride solution
    »ý¸®½Ä¿°¾×(ßæìµãÝç¤äû), »ý½Ä¼ö(ßæãÝâ©) .
  • isotonic solution
    µîÀ强 ¿ë¾×(ÔõíþàõéÁäû), µîÀå¾×.
  • low ionic strenglh salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • solution
    ¿ë¾×(éÁäû)
  • solution hybridization
    ¿ë¾×(éÁäû) Æ¢±âÇü¼º(û¡à÷)
  • standard solution
    Ç¥ÁØ¿ë¾×(øöñÞéÁäû)
  • supersaturated solution
    °úÆ÷È­ ¿ë¾× (ΦøéûúéÁäû)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ringer's lactate solution
    ¸µ°Å¾×
    tri
  • Ringer's solution
    ¸µ°Å ¾×
  • solid solution
    °í¿ëü
    1. °íü »óÅ¿¡¼­ ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ¼­·Î ³ì¾Æ ÀÖ´Â ÇÕ±Ý. 2. ¹°¿¡ ½Ä¿°À» ¼¯¾î¼­ ´ÜÀÏ»óÀÇ ¿ë¾×À» ¸¸µå´Â °Í°ú °°ÀÌ, °íü »óÅ¿¡¼­µµ ÇÑ ±Ý¼Ó¿¡ ´Ù¸¥ ±Ý¼Ó ¶Ç´Â ºñ±Ý¼ÓÀÌ ¼¯¿© µé¾î°¡ ´ÜÀÏ»óÀÇ °íü »óÅÂÀÇ ¿ë¾×À» ¸¸µå´Â °æ¿ì°¡ Àִµ¥ À̰ÍÀÌ °í¿ëüÀÌ´Ù.
  • solution tablet
    ¿ëÇØÁ¤
  • stock solution
    ¿ø¾×
  • strong ammonia solution
    °­ ¾Ï¸ð´Ï¾Æ¼ö
    ¹«»ö Åõ¸íÇÑ °­ ¾ËÄ®¸®¼º ¿ë¾×. 27¡­30%ÀÇ ¾Ï¸ð´Ï¾Æ¸¦ ÇÔÀ¯ÇÑ´Ù. ¿ë¸Å ¹× ¾Ï¸ð´Ï¾Æ¿øÀ¸·Î »ç¿ëµÈ´Ù.
  • supersaturated solution
    °úÆ÷È­ ¾×
    ¿µ±¸È÷ ÇÔÀ¯µÉ ¼ö ÀÖ´Â ¾ç ÀÌ»óÀÇ ¿ëÁúÀÌ ³ì¾Æ ÀÖ´Â ºÒ¾ÈÁ¤ÇÑ ¿ë¾×.
  • thymol solution
    Ƽ¸ô ¿ë¾×
  • toluidine blue solution
    toluidine blue ¿ë¾×
  • unsaturated solution
    ºÒÆ÷È­ ¾×
  • volumetric solution
    ¿ë·®¾×
    1 ¸®ÅÍ Áß¿¡ ¿ëÁúÀÇ ±×·¥ »ó´ç¼ö¸¦ ÇÔÀ¯ÇÏ´Â ¿ë¾×.
  • antro-oral opening
    »ó¾Çµ¿ õ°ø
  • character oral
    ±¸°­±â ¼º°Ý
  • fecal-oral
    ¹è¼³¹°À» ÅëÇÑ
  • focal oral mucitis
    ±¹¼Ò¼º ±¸°­ Á¡¾×Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Gey's solution A salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells.
(05 Mar 2000)
glucose solution, hypertonic Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent.
(12 Dec 1998)
volumetric solution A solution made by mixing measured volumes of the components.
(05 Mar 2000)
chemical solution See: solution.
(05 Mar 2000)
Ringer's solution A solution resembling the blood serum in its salt constituents; it contains 8.6 g of NaCl, 0.3 g of KCl, and 0.33 g of CaCl2 in each 1000 ml of distilled water; used topically for burns and wounds, a salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells.
See: Ringer's injection.
(05 Mar 2000)
molar solution <chemistry> A solution made up of one mole of a compound in enough water to make a thousand millilitres of thesolution.
(09 Oct 1997)
molecular dispersed solution A colloidal solution in which the dispersed phase can be concentrated by centrifugation.
Synonym: dispersion colloid, molecular dispersed solution.
(05 Mar 2000)
colloidal solution A dispersoid, emulsoid, or suspensoid.
Synonym: colloidal dispersion.
(05 Mar 2000)
Weigert's iodine solution An iodine-potassium iodide mixture used as a reagent to alter crystal and methyl violet so that they are retained by certain bacteria and fungi.
(05 Mar 2000)
Monsel solution Ferric subsulfate solution used to coagulate superficial bleeding such as that following skin biopsy.
(05 Mar 2000)
monsel's solution <medicine> An aqueous solution of Monsel's salt, having valuable styptic properties.
See: Monsel's salt.
Source: Websters Dictionary
(01 Mar 1998)
Hanks' solution A salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells; two variations contain CaCl2, MgSO4-7H2O, KCl, KH2PO4, NaHCO3, NaCl, Na2HPO4-2H2O, and d-glucose.
(05 Mar 2000)
Hartmann's solution A solution containing NaCl, sodium lactate, CaCl2(dihydrate), and KCl in distilled water; used for the same purposes as Ringer's solution.
Synonym: Hartmann's solution.
(05 Mar 2000)
Hartman's solution A solution used to desensitise dentin in dental operations; contains thymol, ethyl alcohol, and sulfuric ether.
(05 Mar 2000)
Hayem's solution <haematology> A blood diluent used prior to counting red blood cells.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á